Digital health strategies to boost lung cancer screening in safety-net clinics
Official title: Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics (LUNG-IS) - PATIENT
Run by University of Utah · NCT07716280 · Data updated 2026-11-12
A program tests whether digital tools like text messages, chat bots, video, and navigation support can help more eligible patients in safety-net clinics get lung cancer screening.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | July 21, 2026 |
| Trial ID | NCT07716280 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50–80 who currently or formerly smoked, speak English or Spanish, and own a mobile phone capable of receiving text messages.
✕Probably not a fit
Patients without access to a mobile phone or who do not smoke may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study uses a mixed-methods, pre-post design in three Utah safety-net clinics to see if digital health tools and patient navigation increase lung cancer screening uptake. It applies implementation science frameworks to understand what helps or hinders adoption of screening, decision making, and logistics. The Centralized Hub coordinates eligibility checks, shared decision making, referrals, and screening logistics via text, telehealth, and other technologies. The intervention includes text messaging, chat bot assistance, video content, and proactive/reactive navigation to support patients through the screening process. The population is adults aged 50–80 who smoke or have smoked, who speak English or Spanish, and have access to a mobile phone able to receive texts.
Why it matters
Potential benefit: If successful, the approach could increase screening rates among low-resource populations and make lung cancer screening more accessible.
How similar studies have gone: Previous work in similar settings suggests digital outreach and navigation can improve screening uptake, but the extent of impact in safety-net clinics is still being evaluated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current or former, male and female, smokers. * Age 50-80. * Primary language English or Spanish. * Have a phone that can send/receive text messages. Exclusion Criteria: * Patients who have never smoked. * Patients who are under the age of 50 or above the age of 80. * Primary language other than English or Spanish. * Do not have access to a phone that can send/receive text messages.
Where it's running
-
Huntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, United States Recruiting
Study contacts
- Principal investigator: Chelsey Schlechter, MPH, PhD — Huntsman Cancer Institute
- Study coordinator: Indy Li, MS
- Email: indy.li@hci.utah.edu
- Phone: 801-213-5697
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.